Insider trades
Adsett Roger, Director of Definium Therapeutics DFTX, has filed 0 purchases and 38 sales on the open market. Over the past 12 months that comes to a net sale of $16.3M. The latest trade was on 06/11.
Adsett Roger
Director
- Company
- Definium Therapeutics DFTX
- First filing
- 23/01/06
- Trades
- 62 trades
- Buys / sales
- 0 / 38
- 12-month net buying
- −$16.3M
- Last trade
- 06/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
InsmedINSM | Open-market sale | 06/03 | 06/05 | 2,370 sh | $102.27 | $242,379.9 | −2.3% |
InsmedINSM | Open-market sale | 05/13 | 05/15 | 5,837 sh | $116.18 | $678,142.66 | −5.5% |
INSM | Open-market sale10b5-1 plan | 04/01 | 04/03 | 88,060 sh3 trades | $164.63avg. | $14,497,650.61 | −45.2% |
InsmedINSM | Open-market sale | 02/03 | 02/04 | 791 sh | $156.17 | $123,530.47 | −0.7% |
INSM | Open-market sale | 01/06–01/08 | 01/08 | 4,290 sh3 trades | $174.06avg. | $746,710.74 | −3.8% |
INSM | Open-market sale | 25/08/19 | 25/08/21 | 25,000 sh2 trades | $127.58avg. | $3,189,585.95 | −19.1% |
INSM | Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 10,686 sh2 trades | $98.82avg. | $1,056,003.52 | −7.6% |
InsmedINSM | Open-market sale | 25/06/03 | 25/06/04 | 1,860 sh | $71.50 | $132,990 | −1.3% |
INSM | Open-market sale | 25/05/13–25/05/14 | 25/05/15 | 9,407 sh2 trades | $67.36avg. | $633,653.67 | −6.4% |
INSM | Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 42,975 sh3 trades | $78.61avg. | $3,378,066.75 | −22.7% |
INSM | Open-market sale | 25/02/06–25/02/07 | 25/02/07 | 45,705 sh2 trades | $80.90avg. | $3,697,401.5 | −19.5% |
InsmedINSM | Open-market sale10b5-1 plan | 25/01/14 | 25/01/16 | 1,457 sh | $68.72 | $100,125.04 | −1.0% |
INSM | Open-market sale10b5-1 plan | 25/01/07–25/01/10 | 25/01/10 | 9,228 sh4 trades | $64.78avg. | $597,758.76 | −5.9% |
InsmedINSM | Open-market sale10b5-1 plan | 24/05/17 | 24/05/17 | 5,945 sh | $25.09 | $149,160.05 | −3.8% |
InsmedINSM | Open-market sale | 24/05/14 | 24/05/15 | 7,857 sh | $25.50 | $200,353.5 | −4.8% |
InsmedINSM | Open-market sale10b5-1 plan | 24/01/12 | 24/01/12 | 5,251 sh | $28.63 | $150,336.13 | −3.4% |
INSM | Open-market sale10b5-1 plan | 24/01/09–24/01/10 | 24/01/11 | 7,373 sh2 trades | $29.08avg. | $214,422.65 | −4.6% |
InsmedINSM | Open-market sale | 24/01/05 | 24/01/05 | 3,042 sh | $29.21 | $88,856.82 | −1.9% |
InsmedINSM | Open-market sale10b5-1 plan | 23/06/13 | 23/06/15 | 8,981 sh | $19.32 | $173,512.92 | −5.6% |
INSM | Open-market sale | 23/05/15–23/05/17 | 23/05/17 | 6,816 sh3 trades | $18.66avg. | $127,190.64 | −4.1% |
